The effectiveness of alteplase and urokinase in restoring adequate hemodialysis blood-flow rates was examined. A retrospective review of the medical records of hemodialysis patients with central ...

Discover all the brand names or Trade names of generic drug called Urokinase. This serves as a crucial reference for healthcare professionals, patients, caregivers, and anyone looking to ...

The main flavonol of green tea, epigallocatechin-3-gallate (EGCG), inhibits urokinase 2, one of the hydrolases implicated in tumor invasion. Moreover, green tea consumption by mice significantly ...

a Based on the 2003 Red Book average wholesale price of $538.42 per 250,000-IU vial and $0.17 and $0.05 per syringe and cap, respectively.

Heart disease, including heart attacks and strokes, remains the leading cause of death in the United States. Despite efforts ...

MNPR-101 is Monopar’s proprietary first-in-class humanized monoclonal antibody that targets cancers expressing the urokinase ...

They found that T-cells can be used to fight off another type of cell called the uPAR (urokinase plasminogen activator ...

(RTTNews) - Monopar Therapeutics Inc. (MNPR), Thursday announced positive early data from its ongoing open-label MNPR-101-Zr Phase 1 trial, confirming the compound's tumor-targeting ability in humans.

Researchers identified several inflammatory circulating proteins that could be useful biomarkers for predicting outcomes in ...

The most common clot-busting drugs include Activase (alteplase), Streptase (streptokinase), and Kinlytic (urokinase). Surgery ...

MNPR-101 is Monopar’s proprietary first-in-class humanized monoclonal antibody that targets cancers expressing the urokinase WILMETTE, Ill., Sept. 04, 2024 (GLOBE NEWSWIRE) -- Monopar Therapeutics Inc ...

MNPR-101 is Monopar’s proprietary first-in-class humanized monoclonal antibody that targets cancers expressing the urokinase WILMETTE, Ill., Sept. 04, 2024 (GLOBE NEWSWIRE) -- Monopar Therapeutics Inc ...